SORIN Group is using KIKA Clinical Solutions' advanced EDC platform for clinical trial asset management on two open observational, multi-center, Real Life Registries to evaluate the effectiveness of SORIN Heart Valves.

KIKA provides the Veracity advanced EDC platform for clinical asset management to the pharmaceutical, biotechnology and medical device industries.

SORIN Group is a global medical device company and a provider in the treatment of cardiovascular diseases

The company also develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.

KIKA CEO Linda Beneze said they are pleased that SORIN has continued to work with the company for their clinical trial needs and they are excited that they now have the opportunities Veracity offers to collect, protect and maximize their most important clinical asset their data.